India's Covaxin shot 78% effective against coronavirus, say developers

  • >> Reuters
    Published: 2021-04-21 22:13:26 BdST

A medic fills a syringe with COVAXIN, an Indian government-backed experimental COVID-19 vaccine, before administering it to a health worker during its trials, at the Gujarat Medical Education and Research Society in Ahmedabad, India, November 26, 2020. REUTERS

India's only domestically developed COVID-19 vaccine, Covaxin, has been found to be 78% effective in a second analysis of clinical trials done around the country, its makers said on Wednesday.

"I am very pleased to state that Covaxin ... has shown the efficacy of 78% in the second interim analysis," said Balram Bhargava, the chief of the state-run Indian Council of Medical Research that has created the vaccine with Bharat Biotech.

The first analysis released in March had shown an efficacy rate of 81%.